Gongwin Biopharm Holdings Co., Ltd. logo

Gongwin Biopharm Holdings Co., Ltd. (6617)

Market Closed
16 Oct, 05:30 AM
TWSE TWSE
NT$
126. 50
+6
+4.9793%
NT$
- Market Cap
- P/E Ratio
116% Div Yield
1.1M Volume
- Eps
NT$ 120.5
Previous Close
Add Transaction
Day Range
119.5 128
Year Range
58.3 149
Want to track 6617 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Gongwin Biopharm Holdings Co., Ltd. (6617) Statistics

Valuation metrics

Market Cap -
Enterprise value 13.81B
Trailing P/E (ttm) -88.15
Forward P/E -
PEG ratio 1.18
Price/Sales (ttm) 341.61
Price/Book (mrq) 6.2
Enterprise Value/Revenue 327.02
Enterprise Value/EBITDA -49.18

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 553.77K
Average volume (90 days) 843.66K

Price summary

52-Week low 58.3
52-Week high 149
Beta -
50-Day moving average 128.42
200-Day moving average 89.59

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 253:250
Last split Date 20 Jul 2022

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -3.9%
Operating margin -5.74%

Operational effectiveness

Return on assets -0.06%
Return on equity -0.07%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.35
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.36
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 13.79
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 8.19%
Book value per share (mrq) 19.23

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -